2010 - Fellow of the American Academy of Arts and Sciences
2008 - Fellow of the American Association for the Advancement of Science (AAAS)
Gary J. Nabel focuses on Virology, Immunology, Virus, Antibody and Molecular biology. Gary J. Nabel has researched Virology in several fields, including Monoclonal antibody and Glycoprotein. His Immunology research includes elements of Viral vector and AIDS Vaccines.
His study connects Immunity and Virus. His Antibody study incorporates themes from Peptide sequence and Binding site. Gary J. Nabel works mostly in the field of Molecular biology, limiting it down to topics relating to Transfection and, in certain cases, Genetic enhancement and Transmembrane protein, as a part of the same area of interest.
Gary J. Nabel mainly focuses on Virology, Immunology, Antibody, Virus and Immune system. His Virology research focuses on Vaccination in particular. The study incorporates disciplines such as AIDS Vaccines, Acquired immunodeficiency syndrome and Viral vector in addition to Immunology.
Gary J. Nabel has included themes like Molecular biology and Genetic enhancement in his Viral vector study. In most of his Antibody studies, his work intersects topics such as Glycoprotein. His Immune system research is multidisciplinary, incorporating perspectives in Vector, Adenoviridae and Antigen.
Gary J. Nabel mostly deals with Virology, Antibody, Immunology, Virus and Immune system. Gary J. Nabel interconnects Epitope, Immunization, Antigen, Immunity and Monoclonal antibody in the investigation of issues within Virology. His Antibody study integrates concerns from other disciplines, such as Protein structure, Potency, Binding site and Glycan.
As a part of the same scientific study, Gary J. Nabel usually deals with the Immunology, concentrating on HIV vaccine and frequently concerns with Vector. Gary J. Nabel works mostly in the field of Virus, limiting it down to concerns involving Fusion protein and, occasionally, Ectodomain. His Immune system research incorporates themes from Cell culture and AIDS Vaccines, Acquired immunodeficiency syndrome.
His scientific interests lie mostly in Virology, Antibody, Immunology, Virus and Immunity. Gary J. Nabel is interested in Ebolavirus, which is a field of Virology. Gary J. Nabel focuses mostly in the field of Antibody, narrowing it down to topics relating to Binding site and, in certain cases, Potency.
His work focuses on many connections between Immunology and other disciplines, such as AIDS Vaccines, that overlap with his field of interest in Regulation of gene expression, Cytotoxic T cell, CD8 and Microarray analysis techniques. The Immunity study which covers Inactivated vaccine that intersects with Influenza vaccine. The various areas that he examines in his Immune system study include Cell culture, Vaccine trial, Cell killing and DNA repair.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Gary Nabel;David Baltimore.
Nature (1987)
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
Laurelee Osborn;Steven Kunkel;Gary J. Nabel.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp.
Science (2010)
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans
Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang.
Science (2010)
HIV vaccine design and the neutralizing antibody problem
Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff.
Nature Immunology (2004)
Site-specific gene expression in vivo by direct gene transfer into the arterial wall.
Elizabeth G. Nabel;Gregory Plautz;Gary J. Nabel.
Science (1990)
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
Elizabeth G. Nabel;Gary J. Nabel.
(1992)
Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell.
Nature (2007)
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Neil D. Perkins;Lisa K. Felzien;Jonathan C. Betts;Kwanyee Leung.
Science (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
Brigham and Women's Hospital
Sanofi (United States)
Beth Israel Deaconess Medical Center
National Institutes of Health
National Institutes of Health
Sanofi (France)
National Institutes of Health
Q² Solutions
National Institutes of Health
Monash University
SRI International
École de Technologie Supérieure
Shanghai Jiao Tong University
Technical University of Denmark
Colorado School of Mines
University of Washington
McGill University Health Centre
University of Pennsylvania
University of Miami
University of Toronto
Newcastle University
University of Oklahoma
University of Michigan–Ann Arbor
University of Copenhagen
University of Pennsylvania